Le Lézard
Classified in: Health
Subject: STP

Pennsylvania Department of Health Grants Medical Marijuana Permits for Dispensaries


HARRISBURG, Pa., June 29, 2017 /PRNewswire-USNewswire/ -- The Pennsylvania Department of Health today granted 27 dispensary permits for medical marijuana dispensaries. The permittees will now have six months in which to become operational, before they can begin dispensing medical marijuana.

"This has been a highly competitive process and the department received hundreds of quality applications," said John Collins, Director of the Office of Medical Marijuana. "Once this program is fully operational, patients with serious medical conditions will have locations throughout the commonwealth where they can purchase medication to help in their treatment. We remain on track to provide medication to patients in 2018."

There will be a total of 52 dispensaries located throughout the commonwealth.  Each of the 27 dispensary permit holders is eligible to open a total of three locations. Some dispensary permit holders have opted not to open all eligible locations at this time. A complete list of locations is available on the Department of Health website at www.health.pa.gov.

The 27 permits were issued to:
Region 1: Southeast

County

Permit ID

Business Name

Berks

D?1050-17

SMPB Retail, LLC

Bucks

D?1090-17

Franklin Bioscience-Penn, LLC

Chester

D?1067-17

Chamounix Ventures, LLC

Delaware

D?1068-17

AES Compassionate Care, LLC

Lancaster

D?1069-17

BAY, LLC

Montgomery

D?1037-17

Ilera Healthcare, LLC

Montgomery

D?1053-17

TerraVida Holistic Centers, LLC

Philadelphia

D?1044-17

PharmaCann Penn, LLC

Philadelphia

D?1087-17

Restore Integrative Wellness Center, LLC

Philadelphia

D?1034-17

Holistic Pharma, LLC

Region 2: Northeast

County

Permit ID

Business Name

Lehigh

D?2006-17

Mission Pennsylvania II, LLC

Lackawanna

D?2009-17

Columbia Care Pennsylvania, LLC

Luzerne

D?2013-17

Justice Grown Pennsylvania, LLC

Northampton

D?2035-17

GuadCo, LLC

Region 3: Southcentral

County

Permit ID

Business Name

Blair

D?3016-17

Lebanon Wellness Center, LLC

Cumberland

D?3023-17

Organic Remedies, Inc.

Dauphin

D?3025-17

KW Ventures Holdings, LLC

York

D?3029-17

Cansortium Pennsylvania, LLC

Region 4: Northcentral

County

Permit ID

Business Name

Centre

D?4007-17

PA Health & Wellness, LLC

Lycoming

D?4012-17

Keystone Center of Integrative Wellness, LLC

Region 5: Southwest

County

Permit ID

Business Name

Allegheny

D?5030-17

Maitri Medicinals, LCC

Allegheny

D?5050-17

Keystone Relief Centers, LLC

Butler

D?5016-17

Cresco Yeltrah, LLC

Washington

D?5026-17

The Healing Center, LLC

Westmoreland

D?5006-17

Keystone Integrated Care, LLC

Region 6: Northwest

County

Permit ID

Business Name

Erie

D?6002-17

GTI Pennsylvania, LLC

McKean

D?6009-17

Dubois Wellness Center, LLC

Individual dispensary locations, score cards for all dispensary applicants and redacted applications for the 27 dispensary permit holders are available on the Medical Marijuana section on the Department of Health website at www.health.pa.gov . Redacted applications for all grower/processors are also available on the website.

The Office of Medical Marijuana received 457 applications: 177 for growers and processors; and 280 for dispensaries.

The Medical Marijuana Act was signed into law by Governor Tom Wolf on April 17, 2016. Since that time, the department has:

The Medical Marijuana Act became effective on May 17, 2016, and is expected to be fully implemented in early 2018. The Medical Marijuana Program will offer medical marijuana to patients who are residents of Pennsylvania and under a practitioner's care for the treatment of a serious medical condition as defined by Act 16. 

Questions about the Medical Marijuana Program can be emailed to [email protected]. Information is also available on the Department of Health website at www.health.pa.gov or by following us on Facebook and Twitter.

MEDIA CONTACT: April Hutcheson, 717-787-1783 or [email protected]

 

SOURCE Pennsylvania Department of Health


These press releases may also interest you

at 02:05
Today AstraZeneca revealed its bold ambition to deliver $80 billion in Total Revenue by 2030, up from $45.8 billion in 2023. This will be achieved through significant growth in its existing oncology, biopharmaceuticals and rare disease portfolio, and...

at 01:18
. Hansa Biopharma, "Hansa" (STOCKHOLM: HNSA), today announced data featuring imlifidase will be presented at the American Transplant Congress (ATC), the joint annual meeting of the American Society of Transplant Surgeons (ASTS) and the American...

at 01:05
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an investigational oral therapy, in combination with...

at 01:05
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that in an abstract published on 14 May 2024 for the European Hematology Association 2024 Congress on SAR443579/IPH6101, submitted by...

at 00:01
Celltrion USA announced today...

at 00:01
SonarMD today presented positive results from two large, longitudinal studies evaluating several major drivers of medical costs in people living with Inflammatory Bowel Disease (IBD) ? defined as people living with ulcerative colitis or Crohn's...



News published on and distributed by: